GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioasis Technologies BIOAF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in CAD, from our data supplier.

FY2021

Revenue

C$4.1m

FY2014FY2021

Net income

C$698,410

FY2014FY2021

Free cash flow

C$1.8m

FY2014FY2021

Shareholders' equity

C$407,196

FY2014FY2021

Income statement

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
RevenueC$4.1mC$606,384C$1.4mC$589,844C$512,966C$369,124——
Research and developmentC$1.2mC$2.0mC$2.0mC$946,808C$783,778C$841,048C$1.4mC$2.0m
Operating income−C$858,039−C$5.2m−C$6.2m−C$5.2m−C$3.0m−C$2.6m−C$2.8m−C$3.6m
Net incomeC$698,410−C$4.1m−C$3.5m−C$5.3m−C$3.0m−C$2.6m−C$2.8m−C$3.6m
Diluted earnings per share0.01-0.06-0.05-0.09-0.06-0.06-0.06-0.08

Balance sheet

At each fiscal year end

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assetsC$3.3mC$941,794C$1.7mC$1.2mC$1.1mC$2.2mC$2.2mC$2.6m
Cash and short-term investmentsC$2.7mC$576,371C$1.4mC$677,972C$554,285C$1.6mC$1.6mC$1.8m
Total liabilitiesC$2.9mC$3.4mC$2.3mC$787,661C$747,523C$433,739C$206,525C$187,662
DebtC$113,531C$1.0m——C$17,160C$321,273——
Shareholders' equityC$407,196−C$2.5m−C$546,656C$434,146C$363,405C$1.7mC$2.0mC$2.4m
Shares outstanding72m65m64m59m52m46m44m44m

Cash flow

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operationsC$1.8m−C$3.3m−C$3.2m−C$3.7m−C$1.2m−C$1.5m−C$2.0m−C$2.8m
Capital spending——−C$2,062−C$107,713−C$43,513−C$2,456−C$750−C$678
Free cash flowC$1.8m−C$3.3m−C$3.2m−C$3.8m−C$1.3m−C$1.5m−C$2.0m−C$2.8m

Latest quarters

By quarter end

Nov 2022Aug 2022May 2022Feb 2022Nov 2021Aug 2021May 2021Feb 2021
RevenueC$148,936C$120,440——C$37,725———
Operating income−C$698,860−C$899,661−C$629,650−C$2.1m−C$776,273−C$1.2m−C$1.0m−C$1.4m
Net income−C$985,670−C$1.1m−C$233,213−C$566,764−C$1.3m−C$580,287−C$540,654−C$1.1m
Diluted earnings per share-0.01-0.01-0.00-0.01-0.02-0.01-0.01-0.02
Cash from operations—————−C$1.0m——
Total assetsC$1.8mC$2.3mC$1.3mC$2.3mC$3.0mC$4.0mC$2.4mC$3.3m
Cash and short-term investmentsC$156,515C$568,226C$764,968C$1.7mC$2.6mC$3.5mC$1.9mC$2.7m
DebtC$2.2mC$2.0mC$1.8mC$1.9mC$2.0mC$1.8mC$108,044C$113,531
Shareholders' equity−C$2.7m−C$1.7m−C$2.1m−C$1.9m−C$1.6m−C$306,248−C$50,787C$407,196

Valuation history

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Price to earnings—0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.0
Price to sales0.20.00.10.00.10.10.2——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1500%-95%256%-88%-17%60%-43%-53%-37%-1%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.